Logo Logo

Publications by Neureiter, D.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Stintzing, S.; Price, B.; Knight, L.; McCavigan, A.; Walker, S.; Harkin, P.; Kennedy, R.; Neureiter, D.; Held, S.; Jung, A.; Kirchner, T.; Heinemann, V. (2017): Predictive assay for anti-angiogenic agents (AADx) identifies molecular subgroups of RASwt mCRC with differential efficacy of FOLFIRI plus bevacizumab in the FIRE-3 (AIO KRK-0306) trial. In: Annals of Oncology, Vol. 28

Laurent-Puig, P.; Grisoni, M.-L.; Heinemann, V.; Fontaine, K.; Vazart, C.; Decaulne, V.; Rousseau, F.; Courtieu, B.; Lieabert, F.; Jung, A.; Neureiter, D.; Thiebaut, R.; Stintzing, S. (2016): MiR-31-3p is a predictive biomarker of cetuximab response in FIRE3 clinical trial. In: Annals of Oncology, Vol. 27

This list was generated on Fri Apr 23 01:41:27 2021 CEST.